Myriad Genetics | MYGN - Loan Capital


Myriad Genetics reported $119.9M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 0 Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Bio-Rad Laboratories USD 1.2B 300K Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Danaher USD 18.42B 1.58B Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
Illumina USD 1.49B 496M Dec/2025
J&J USD 39.44B 30M Dec/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Myriad Genetics USD 119.9M 400K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quest Diagnostics USD 5.17B 4M Dec/2025
Quidel USD 2.47B 2.47B Dec/2025
Repligen USD 542.21M 4.29M Dec/2025
Revvity USD 2.63B 543K Dec/2025
Standard Biotools USD 299K 0 Dec/2025
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Veracyte USD 0 0 Mar/2025
Waters USD 1.41B 460.24M Dec/2025